Fate Therapeutics, Inc.FATENASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank29
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-147.70M
Near historical average
Percentile
P29
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-144.39M
Historical baseline
PeriodValueYoY Change
2025$-147.70M+29.8%
2024$-210.28M-10.4%
2023$-190.51M+38.2%
2022$-308.39M-42.1%
2021$-216.99M-69.4%
2020$-128.09M-27.2%
2019$-100.73M-50.1%
2018$-67.09M-59.3%
2017$-42.13M-31.8%
2016$-31.96M-